Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Short Interest Update

Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) was the recipient of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 2,400 shares, a growth of 20.0% from the December 15th total of 2,000 shares. Based on an average trading volume of 15,700 shares, the short-interest ratio is presently 0.2 days.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Tema Cardiovascular and Metabolics ETF stock. Sterling Investment Advisors Ltd. grew its holdings in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) by 3.7% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 158,695 shares of the company’s stock after buying an additional 5,605 shares during the quarter. Tema Cardiovascular and Metabolics ETF accounts for approximately 1.4% of Sterling Investment Advisors Ltd.’s holdings, making the stock its 23rd biggest holding. Sterling Investment Advisors Ltd. owned 6.40% of Tema Cardiovascular and Metabolics ETF worth $5,332,000 at the end of the most recent quarter.

Tema Cardiovascular and Metabolics ETF Stock Down 0.7 %

Tema Cardiovascular and Metabolics ETF stock traded down $0.19 during trading hours on Friday, hitting $28.70. The stock had a trading volume of 10,235 shares, compared to its average volume of 12,749. The company has a 50-day moving average of $30.62 and a two-hundred day moving average of $32.85. Tema Cardiovascular and Metabolics ETF has a fifty-two week low of $28.56 and a fifty-two week high of $36.03. The company has a market cap of $66.30 million, a PE ratio of 32.89 and a beta of 0.93.

Tema Cardiovascular and Metabolics ETF Dividend Announcement

The company also recently announced a dividend, which was paid on Thursday, December 12th. Investors of record on Wednesday, December 11th were paid a $0.4693 dividend. The ex-dividend date of this dividend was Wednesday, December 11th.

About Tema Cardiovascular and Metabolics ETF

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.